Zobrazeno 1 - 2
of 2
pro vyhledávání: '"K J, van Doorn"'
Publikováno v:
Acta Anaesthesiologica Scandinavica. 52:1259-1264
Background: Drotrecogin alfa activated (DrotAA) is licensed for treatment of patients with severe sepsis and organ failure. Among the latter, acute kidney injury (AKI), defined as the persistence of oligo-anuria following adequate resuscitation, is o
Publikováno v:
Acta anaesthesiologica Scandinavica. 52(9)
Drotrecogin alpha activated (DrotAA) is licensed for treatment of patients with severe sepsis and organ failure. Among the latter, acute kidney injury (AKI), defined as the persistence of oligo-anuria following adequate resuscitation, is one of the m